These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 33789695)

  • 21. Trinucleotide insertion in the SMN2 promoter may not be related to the clinical phenotype of SMA.
    Harahap NI; Takeuchi A; Yusoff S; Tominaga K; Okinaga T; Kitai Y; Takarada T; Kubo Y; Saito K; Sa'adah N; Nurputra DK; Nishimura N; Saito T; Nishio H
    Brain Dev; 2015 Aug; 37(7):669-76. PubMed ID: 25459970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history in spinal muscular atrophy Type I in Taiwanese population: A longitudinal study.
    Ou SF; Ho CS; Lee WT; Lin KL; Jones CC; Jong YJ;
    Brain Dev; 2021 Jan; 43(1):127-134. PubMed ID: 32878721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal muscular atrophy: a time for screening.
    Prior TW
    Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA).
    Rouzier C; Chaussenot A; Paquis-Flucklinger V
    Arch Pediatr; 2020 Dec; 27(7S):7S9-7S14. PubMed ID: 33357600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating Spinal Muscular Atrophy Analysis by Next-Generation Sequencing into a Comprehensive Multigene Panel for Neuromuscular Disorders.
    Tan CA; Westbrook MJ; Truty R; Kvitek DJ; Kennemer M; Winder TL; Shieh PB
    Genet Test Mol Biomarkers; 2020 Oct; 24(10):616-624. PubMed ID: 32721234
    [No Abstract]   [Full Text] [Related]  

  • 27. Newborn Screening for Spinal Muscular Atrophy: DNA Preparation from Dried Blood Spot and DNA Polymerase Selection in PCR.
    Takeuchi A; Tode C; Nishino M; Wijaya YOS; Niba ETE; Awano H; Takeshima Y; Saito T; Saito K; Lai PS; Bouike Y; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Nov; 65(3):E95-E99. PubMed ID: 32029694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal Muscular Atrophy: Advanced Version of Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E49-E53. PubMed ID: 31956256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2.
    Vill K; Tacke M; König A; Baumann M; Baumgartner M; Steinbach M; Bernert G; Blaschek A; Deschauer M; Flotats-Bastardas M; Friese J; Goldbach S; Gross M; Günther R; Hahn A; Hagenacker T; Hauser E; Horber V; Illsinger S; Johannsen J; Kamm C; Koch JC; Koelbel H; Koehler C; Kolzter K; Lochmüller H; Ludolph A; Mensch A; Meyer Zu Hoerste G; Mueller M; Mueller-Felber W; Neuwirth C; Petri S; Probst-Schendzielorz K; Pühringer M; Steinbach R; Schara-Schmidt U; Schimmel M; Schrank B; Schwartz O; Schlachter K; Schwerin-Nagel A; Schreiber G; Smitka M; Topakian R; Trollmann R; Tuerk M; Theophil M; Rauscher C; Vorgerd M; Walter MC; Weiler M; Weiss C; Wilichowski E; Wurster CD; Wunderlich G; Zeller D; Ziegler A; Kirschner J; Pechmann A;
    J Neurol; 2024 May; 271(5):2787-2797. PubMed ID: 38409538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal muscular atrophy patient detection and carrier screening using dried blood spots on filter paper.
    Harahap NI; Harahap IS; Kaszynski RH; Nurputra DK; Hartomo TB; Pham HT; Yamamoto T; Morikawa S; Nishimura N; Rusdi I; Widiastuti R; Nishio H
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):123-9. PubMed ID: 21942573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission characteristics of SMN from 227 spinal muscular atrophy core families in China.
    Cao Y; Qu Y; Bai J; Cheng M; Jin Y; Wang H; Song F
    J Hum Genet; 2020 May; 65(5):469-473. PubMed ID: 32051521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SMA screening system using dried blood spots on filter paper: application of COP-PCR to the SMN1 deletion test.
    Kato N; Sa'Adah N; Ar Rochmah M; Harahap NI; Nurputra DK; Sato H; Sadewa AH; Astuti I; Haryana SM; Saito T; Saito K; Nishimura N; Nishio H; Takeuchi A
    Kobe J Med Sci; 2015 Jan; 60(4):E78-85. PubMed ID: 25791416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal Muscular Atrophy: New Screening System with Real-Time mCOP-PCR and PCR-RFLP for SMN1 Deletion.
    Niba ETE; Rochmah MA; Harahap NIF; Awano H; Morioka I; Iijima K; Takeshima Y; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Matsuo M; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Jul; 65(2):E44-E48. PubMed ID: 31956255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of survival motor neuron gene conversion in patients with spinal muscular atrophy].
    He SX; Ge XS; Qu YJ; Jin YW; Wang H; Bai JL; Song F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):606-11. PubMed ID: 22161088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation analysis of 419 family and prenatal diagnosis of 339 cases of spinal muscular atrophy in China.
    Sun Y; Kong X; Zhao Z; Zhao X
    BMC Med Genet; 2020 Jun; 21(1):133. PubMed ID: 32552676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
    Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
    Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal muscular atrophy within Amish and Mennonite populations: Ancestral haplotypes and natural history.
    Carson VJ; Puffenberger EG; Bowser LE; Brigatti KW; Young M; Korulczyk D; Rodrigues AS; Loeven KK; Strauss KA
    PLoS One; 2018; 13(9):e0202104. PubMed ID: 30188899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newborn Screening for Spinal Muscular Atrophy in New York State: Clinical Outcomes From the First 3 Years.
    Lee BH; Deng S; Chiriboga CA; Kay DM; Irumudomon O; Laureta E; Delfiner L; Treidler SO; Anziska Y; Sakonju A; Kois C; Farooq O; Engelstad K; Laurenzano A; Hogan K; Caggana M; Saavedra-Matiz CA; Stevens CF; Ciafaloni E
    Neurology; 2022 Oct; 99(14):e1527-e1537. PubMed ID: 35835557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a reliable method for detection of non-homozygous patients with spinal muscular atrophy].
    Long MJ; Song F; Qu YJ; Meng Y; Wang H; Jin YW; Huang SZ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1259-63. PubMed ID: 18844099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.